|
EXOC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.13409999999525E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.918600E-03 |
| Normal-vs-Stage2 |
4.857100E-03 |
| Normal-vs-Stage3 |
1.47669999994715E-06 |
| Normal-vs-Stage4 |
6.239500E-04 |
| Stage1-vs-Stage2 |
3.234200E-01 |
| Stage1-vs-Stage3 |
1.494090E-02 |
| Stage1-vs-Stage4 |
1.770550E-01 |
| Stage2-vs-Stage3 |
5.235400E-01 |
| Stage2-vs-Stage4 |
8.179400E-01 |
| Stage3-vs-Stage4 |
6.753600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.17029999999285E-05 |
| Normal-vs-AfricanAmerican |
1.637790E-02 |
| Normal-vs-Asian |
2.241200E-01 |
| Caucasian-vs-AfricanAmerican |
7.892400E-01 |
| Caucasian-vs-Asian |
7.674000E-01 |
| AfricanAmerican-vs-Asian |
8.711400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.91890000018114E-07 |
| Normal-vs-Female |
1.928340E-02 |
| Male-vs-Female |
5.477500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.755800E-03 |
| Normal-vs-Age(41-60Yrs) |
5.811500E-04 |
| Normal-vs-Age(61-80Yrs) |
5.5159999999943E-05 |
| Normal-vs-Age(81-100Yrs) |
5.596800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.488200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.258600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.097800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.104000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.089990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.042800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.106400E-01 |
| Normal-vs-Grade 2 |
5.202200E-03 |
| Normal-vs-Grade 3 |
3.58769999997399E-06 |
| Normal-vs-Grade 4 |
4.436200000002E-05 |
| Grade 1-vs-Grade 2 |
1.976010E-01 |
| Grade 1-vs-Grade 3 |
2.284300E-02 |
| Grade 1-vs-Grade 4 |
3.265700E-02 |
| Grade 2-vs-Grade 3 |
1.285590E-02 |
| Grade 2-vs-Grade 4 |
1.657810E-02 |
| Grade 3-vs-Grade 4 |
4.649400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.121300E-03 |
| Normal-vs-ccB subtype |
3.52679999999772E-05 |
| ccA subtype-vs-ccB subtype |
3.210200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.395100E-04 |
| Normal-vs-N1 |
3.068400E-01 |
| N0-vs-N1 |
9.054000E-01 |
|
|
